AM-Era Technologies Sagl

The conception, development, refinement, production and distribution of products and services based on and/or derived from the human amniotic membrane, for all treatments of regenerative medicine and surgery in compliance with current regulations. The production and distribution of medical devices associated with the amniotic membrane or intended for its processing and transformation. The creation of biomedical products that involve the procurement, banking and use of the human amniotic membrane. The company may also carry out all commercial or other activities related to the company's purpose in Switzerland and abroad. This also includes investments in securities and real estate, the acquisition of participations in companies and enterprises, participation in consortia and groupings.